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Introduction
Oligohydramnios developing early in pregnancy is less
common, and the fetal outcomes are usually poor. This
is because prolonged decrease in amniotic fluid may
cause compression sequences, such as pulmonary
hypoplasia, muscle hypotrophy or joint constriction.
Early-onset oligohydramnios may be caused by preterm
premature rupture of membranes (pPROM) or
decreased secretion of amniotic fluid. Early rupture 
of membranes always leads to poor prognosis despite
antepartum intervention such as amnioinfusion. Oligo-
hydramnios without ruptured membranes implies fetal
urinary tract malformations or chromosome anomaly.
However, even normal infants may suffer from the
consequences of oligohydramnios, such as amniotic
band syndrome, congenital postural deformities, pul-
monary hypoplasia and cord compression. Decades
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SUMMARY
Objective: In the past, oligohydramnios occurring early during the secondary trimester was the reason to termi-
nate the pregnancy because of poor prognosis. Even though amnioinfusion has been reported for improving the
prognosis of the infant, it is still not frequently used because of unfavorable results. We present our experience
with amnioinfusion for oligohydramnios with or without preterm premature rupture of membranes.
Materials and Methods: A retrospective study was performed from July 2005 to December 2006 in our hospital.
Amnioinfusions were performed in pregnant women found with oligohydramnios during their second trimesters.
Chromosomal studies were recommended and performed under informed consent. Level II sonography was
performed after each amnioinfusion. Magnetic resonance imaging was arranged for those with suggested urinary
tract malformations.
Results: Seventeen cases were included in our study. No mother was exposed to drugs that have been associ-
ated with oligohydramnios. The women received one to six procedures of amnioinfusion separately with a total
of 28 procedures. Only one procedure failed. No chromosomal anomalies were found. Fetal anomalies were
found after amnioinfusion in five cases. One woman had preterm delivery within 1 week after amnioinfusion. In
the four cases of oligohydramnios with rupture of membranes, one case had a healthy full-term baby delivered.
In the thirteen cases of oligohydramnios without rupture of membranes, there were two preterm infants deliv-
ered before 34 weeks of gestation, including pulmonary hypoplasia in one neonate, and three healthy babies
delivered after 35 weeks of gestation.
Conclusion: Amnioinfusion performed the first time might provide some benefits for those with early-onset
oligohydramnios, such as to provide confirmation of rupture of membranes, detailed sonography examination
and further counseling. We would recommend that this procedure be considered once for these cases. [Taiwan J
Obstet Gynecol 2007;46(4):395–398]
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ago, termination of pregnancy was the standard for
those with early-onset oligohydramnios that indicated
bad prognoses. In recent years, more and more pub-
lished reports in the literature have mentioned that
amnioinfusions can prolong pregnancies and improve
perinatal outcomes in cases of pPROM. We present our
experience with amnioinfusion for patients with oligo-
hydramnios with or without rupture of the membrane
early in the second trimester.
Materials and Methods
A retrospective study was performed at our hospital
from July 2005 to December 2006. We collected the data
of pregnant women who were diagnosed with oligohy-
dramnios (amniotic fluid index [AFI], <5 cm) during
the early second trimester. The AFI was rechecked 1 week
after the initial diagnosis to determine the case of fluid
intake. If oligohydramnios persisted, amnioinfusions
were performed after counseling, using warm, sterile
isotonic sodium chloride solution. If there was fluid
leakage from the vagina after amnioinfusion, pPROM
was diagnosed or confirmed. Those women whose
membranes had ruptured were hospitalized and empiric
antibiotics were prescribed for them. Chromosomal
studies of washed amniotic fluid was performed under
informed consent. All of the cases received level II
sonography after amnioinfusion. Magnetic resonance
imaging was arranged for those with suggested urinary
tract malformations.
The subsequent amniotic fluid volume was meas-
ured with AFI using sonography every week during 
the first month after diagnosis, then once a month
until birth. During the pregnancies, subsequent serial
amnioinfusions were performed when oligohydramnios
persisted and patients requested for the procedure
after counseling.
Results
We collected the data from 17 pregnant women diag-
nosed with oligohydramnios, with gestational age rang-
ing from 15 to 25 weeks and maternal age from 20 to
37 years. Fifteen cases were singleton pregnancies, one
case was a twin pregnancy with one fetal death, and
another was a triplet pregnancy with two fetal deaths.
Analysis of the maternal health status revealed: one case
of diabetes mellitus, chronic hypertension, placental
previa totalis and placenta increta; one case of sicca
syndrome under steroid therapy; one case of preeclamp-
sia; one case of carcinoma in situ of the uterine cervix,
with conization surgery 2 years prior to pregnancy; and
one case of cervical incompetence, with cervical cerclage
early during the second trimester. No case was exposed
to drugs associated with oligohydramnios.
Amnioinfusion was performed using warm isotonic
sodium chloride solution. The volume ranged from 
250 to 600 mL, and the rate ranged from 10 to 15 mL/
minute. Every case received one to six procedures 
separately with a total of 28 procedures. Only one
procedure failed. Three cases had pPROM before
amnioinfusion, and one case was diagnosed with rup-
ture of membranes after amnioinfusion. Chromosomes
were studied in the 15 cases after informed consent,
and all of them had normal karyotypes except for one.
Fetal anomalies were found in five cases on sonogra-
phy after adequate visualization of the fetal structures
(three cases of fetal renal disease, one case of amniotic
band syndrome and hydrops fetalis, one case of anom-
aly of fetal extremities). Magnetic resonance imaging
was performed in the three cases with suggested renal
disease. One case had bilateral renal dysgenesis, another
had right renal agenesis with left renal dysgenesis, and
the third case had autosomal recessive polycystic kidney
disease. One case had idiopathic severe oligohydram-
nios which lasted more than 2 weeks. Women in six
cases decided to terminate their pregnancies, with fetal
anomalies in five cases and persistent severe oligohy-
dramnios in one case.
One case had preterm delivery within 1 week after
amnioinfusion, and intrauterine fetal death occurred
within 2 weeks of the amnioinfusion in four cases. In the
four cases of oligohydramnios with rupture of mem-
branes, a healthy full-term baby was delivered in one
case (Table 1). In the thirteen cases of oligohydramnios
without rupture of membranes, two cases had preterm
deliveries before 34 weeks of gestation, and three had
healthy babies delivered after 35 weeks of gestation
(Table 2). In the case with placenta previa totalis and
increta with pPROM, the neonate was delivered via
cesarean section at 28 weeks of gestation because of
massive antepartum hemorrhage and chorioamnioni-
tis. This neonate had complication of pulmonary
hypoplasia. In the five live healthy babies, four cases
received amnioinfusion once and one case received
amnioinfusion twice, and the amniotic fluid volume
persisted within normal limits until the pregnancies
were full-term.
Discussion
In most cases, the cause of oligohydramnios is rupture of
the membranes. Other causes such as fetal abnormalities
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(urinary tract malformations or chromosome anom-
alies), drugs, uteroplacental insufficiency, and maternal
disease (hypertension, preeclampsia, diabetes) should
be considered. Healthy infants may also suffer from
the consequences of early onset of severely diminished
amniotic fluid, whether or not the membranes are
intact. Pulmonary hypoplasia is more common as ges-
tational age decreases. In patients with pPROM during
the second trimester, it was shown that the incidence
of pulmonary hypoplasia was 12.9% and the overall
perinatal mortality rate was 54% [1]. In addition, the
perinatal outcomes are correlated with AFI values. AFI
values of <5 cm after pPROM between 24 and 32
weeks’ gestation have been associated with increased
risks of perinatal infections and shorter latency preced-
ing deliveries [2]. Because of poor outcomes, termina-
tion of the pregnancies was the most common decision
in early-onset oligohydramnios several decades ago. The
current trend is different. Augmenting the amniotic fluid
volume may provide diagnostic or therapeutic benefits.
Diagnostic amnioinfusion can determine whether
rupture of the membranes has occurred or not. Chro-
mosome study can also be performed from washed
amniotic fluid during the procedure. By increasing the
amount of amniotic fluid, visualization of the fetal struc-
tures on sonography is markedly improved. The overall
rate of adequate visualization of the fetal structures
improved from 51% to 77% in patients with unexplained
second-trimester oligohydramnios who underwent diag-
nostic antenatal amnioinfusion [3]. In our study, five
fetal anomalies were diagnosed after amnioinfusion,
which provided adequate visualization. Furthermore, the
amount of retained amniotic fluid after the first amnioin-
fusion can determine the suitability for serial therapeutic
amnioinfusion. Those who cannot preserve amniotic
fluid after the first amnioinfusion would not be suitable
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Table 1. Amnioinfusion in oligohydramnios with rupture of membranes
Gestational Number of Gestational Birth body 1-min 5-min 
Case age at diag- amnio- age at weight Agpar Agpar Note
nosis* (wk) infusions delivery (wk) (g) score score
1 19 1 21 310 0 0 Post-cervical cerclage ROM
2 25 1 26 485 0 0 REDV at 25 weeks
3 19 1 20 320 1 0 Triplets with two fetal demises
4 16 2 40 3,830 9 10 Post-amniocentesis ROM
*Diagnosis of oligohydramnios. ROM = rupture of membranes; REDV = reversed end-diastolic velocity in umbilical artery.
Table 2. Amnioinfusion in oligohydramnios without rupture of membranes
Gestational Number of Gestational Birth body 1-min 5-min 
Case age at diag- amnio- age at weight Agpar Agpar Note
nosis* (wk) infusions delivery (wk) (g) score score
1 20 6 29 1,100 0 0 Bilateral kidneys dysgenesis on MRI
2 21 2 28 1,160 1 0 Right renal agenesis and left renal 
dysgenesison MRI
3 23 2 30 1,450 1 0 ARPKD on MRI; ARPKD on autopsy
4 16 1 17 180 0 0 Amniotic band syndrome, hydrops fetalis 
5 18 1 22 480 0 0 Bilateral ulnar and radius genesis
6 15 1 19 300 0 0 Twin with one IUFD at 7 weeks of gestation
7 25 1 27 750 0 0
8 25 2 27 600 0 0
9 18 2 28 1,270 4 5 Diabetes mellitus, chronic hypertension, 
placenta previa totalis with increta; 
ROM at 24 weeks of gestation
10 19 1 40 2,830 9 10 Normal fetal urinary system on MRI
11 23 1 39 2,520 9 10 Sicca syndrome
12 19 1 35 1,480 8 10 Preeclampsia, IUGR
13 24 1 33 1,800 8 9
*Diagnosis of oligohydramnios. MRI = magnetic resonance imaging; ARPKD = autosomal recessive polycystic kidney disease; IUFD = intrauterine fetal death;
ROM = rupture of membranes; IUGR = intrauterine growth retardation.
for serial amnioinfusion. When infused fluids were
retained, subsequent serial amnioinfusion and prolon-
gation of pregnancy were shown to occur in about 75%
of patients [4]. In our five healthy babies, four of their
mothers received amnioinfusion just once and the
other received amnioinfusion twice. This implies that if
the amnioinfusion works well the first time, it will pro-
vide good results. Persistent oligohydramnios after
amnioinfusion indicates poor fetal outcome and/or
severe fetal renal disease, thus an earlier decision could
be made to terminate the pregnancy. In our study, 
six patients who underwent ineffective amnioinfusion
terminated their pregnancies.
Subsequent serial amnioinfusions may provide effec-
tive therapeutic benefits, including prolonged preg-
nancy and decreased risk of pulmonary hypoplasia and
perinatal mortality rate [5–10]. Significant short-term
variability increase just after the amnioinfusion proce-
dure from 5.55 ms to 8.24 ms and after 24 hours up to
7.25 ms was found [11]. Successful outcomes of preg-
nancies with serial saline amnioinfusion from the 16th
week of gestation in pPROM cases have been reported
[12]. In one of our cases with pPROM, even the retained
amniotic fluid after the first amnioinfusion was not
adequate (AFI, 4.8 cm); however, the patient decided
to receive serial amnioinfusion after counseling. Fortu-
nately, her pregnancy proceeded with normal amniotic
fluid, and she was delivered of a healthy neonate at 38
weeks of gestation.
Procedure-related complications such as chorioam-
nionitis or placental abruption, which themselves may
predispose to preterm delivery, may occur even in those
who underwent successful serial amnioinfusion [4]. In
one of our cases, the woman had preterm delivery
within 1 week of the amnioinfusion. In addition, four
other cases resulted in intrauterine fetal demise, which
occurred within 2 weeks of the amnioinfusions.
In past time, most cases of oligohydramnios in early
second trimester tended toward termination of the preg-
nancy because of poor prognosis of the fetus. In our
opinion, the first amnioinfusion might play some role in
early-onset oligohydramnios. It can help with a clearer
diagnosis of the ruptured membranes with the increased
amniotic fluid volume, enabling physicians to visualize
the detailed fetal structures. In addition, it provides a
more accurate prognosis according to the amount of
retained amniotic fluid, as well as the information gath-
ered during the chromosomal studies. All of these pro-
vide more information to be used in the counseling
sessions. Successful therapeutic amnioinfusion improves
pregnancy outcomes. If these patients choose to termi-
nate their pregnancies because of early-onset oligohy-
dramnios, they gain nothing. If they continue with the
pregnancy without any intervention for 1 month, their
babies will have high risk of compression sequences. If
we give them amnioinfusion once, and within 1 week
after the procedure, we can provide them with more and
clearer information so that they can make better choices.
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